Sanni E. Jalava
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
- Co-authors
- Tapio Visakorpi (7 shared papers)Teuvo L.J. Tammela (4 shared papers)Guido W Jenster (2 shared papers)Alfonso Urbanucci (3 shared papers)Kati K. Waltering (2 shared papers)Leena Latonen (2 shared papers)Søren Møller (1 shared paper)Chris H. Bangma (1 shared paper)
- Journals
- Oncogene (2 papers)International Journal of Cancer (2 papers)The Prostate (2 papers)Cardiovascular Diabetology (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- FinlandNetherlandsAustralia
In The Last Decade
Sanni E. Jalava
9 papers receiving 850 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 536
- Molecular Biology 552
- Pulmonary and Respiratory Medicine 135
- Geriatrics and Gerontology 10
- Genetics 61
Countries citing papers authored by Sanni E. Jalava
This map shows the geographic impact of Sanni E. Jalava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanni E. Jalava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanni E. Jalava more than expected).
Fields of papers citing papers by Sanni E. Jalava
This network shows the impact of papers produced by Sanni E. Jalava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanni E. Jalava. The network helps show where Sanni E. Jalava may publish in the future.
Co-authors
The 25 scholars most cited alongside Sanni E. Jalava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 227 | |
| 2 | 2012 | 192 | |
| 3 | 2010 | 139 | |
| 4 | 2010 | 117 | |
| 5 | 2010 | 69 | |
| 6 | 2008 | 67 | |
| 7 | 2008 | 28 | |
| 8 | 2019 | 15 | |
| 9 | 2012 | 12 |
About Sanni E. Jalava
Sanni E. Jalava is a scholar working on Cancer Research, Geriatrics and Gerontology, Molecular Biology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 866 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Prostate Cancer Treatment and Research (2 papers), Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers), RNA modifications and cancer (1 paper), RNA Research and Splicing (1 paper), Cell Adhesion Molecules Research (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Cancer Research (536 citations), Molecular Biology (552 citations), Pulmonary and Respiratory Medicine (135 citations), Geriatrics and Gerontology (10 citations) and Genetics (61 citations). Sanni E. Jalava has collaborated with scholars based in Finland, Netherlands and Australia. Frequent co-authors include Tapio Visakorpi, Teuvo L.J. Tammela, Guido W Jenster, Alfonso Urbanucci, Kati K. Waltering, Leena Latonen, Søren Møller, Chris H. Bangma, Elena S. Martens‐Uzunova and Thomas Litman. Their work appears in journals such as Oncogene, International Journal of Cancer, The Prostate, Cardiovascular Diabetology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.